A detailed history of Precedent Wealth Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Precedent Wealth Partners, LLC holds 334 shares of LLY stock, worth $341,247. This represents 0.08% of its overall portfolio holdings.

Number of Shares
334
Previous 276 21.01%
Holding current value
$341,247
Previous $211 Million 70.45%
% of portfolio
0.08%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 07, 2026

BUY
$799.57 - $1025.28 $46,375 - $59,466
58 Added 21.01%
334 $359 Million
Q3 2025

Oct 14, 2025

SELL
$625.65 - $812.69 $11,261 - $14,628
-18 Reduced 6.12%
276 $211 Million
Q2 2025

Jul 21, 2025

BUY
$713.71 - $898.95 $27,834 - $35,059
39 Added 15.29%
294 $229 Million
Q1 2025

Apr 17, 2025

BUY
$725.72 - $929.72 $185,058 - $237,078
255 New
255 $211 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Precedent Wealth Partners, LLC Portfolio

Follow Precedent Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Precedent Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Precedent Wealth Partners, LLC with notifications on news.